MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • MDS Virtual Congress 2020

    Exploring cognitive aspect of linguistic prosody in Parkinson’s disease

    A. Basirat, S. Pinto, K. Dujardin, L. Defebvre, D. Devos, C. Moreau (Lille, France)

    Objective: To explore the correlation between linguistic prosody and cognition in Parkinson's disease Background: Around 90% of patients with Parkinson’s disease (PD) report speech deficit.…
  • MDS Virtual Congress 2020

    Improved verb use in Parkinson’s disease following intensive voice treatment

    A. Ramage, C. Fox, A. Halpern, L. Ramig (Durham, NH, USA)

    Objective: To identify changes in language production secondary to voice treatment in speakers with Parkinson’s disease (PD). Background: ​Given the role of voice in language…
  • MDS Virtual Congress 2020

    MRI functional connectivity analysis for speech impairment in Parkinson’s disease

    J.P Niguet, R. Viard, T. Guichoux, A. Basirat, L. Defebvre, G. Kuchcinski, D. Devos, C. Moreau (Lille, France)

    Objective: We aimed to investigate underlying modifications of MRI functional connectivity between dysarthric and non-dysarthric patients with Parkinson’s disease and healthy controls. Background: Altered speech…
  • MDS Virtual Congress 2020

    Is acoustic speech analysis applicable for evaluation of swallowing impairment in patients with Parkinson’s disease (PD)?

    N. Madetko, S. Budrewicz (Wrocław, Poland)

    Objective: More than 80% of patients with Parkinson’s disease develop dysphagia during the course of the disease. Methods considered as ‘gold standard’ in swallowing evaluation…
  • MDS Virtual Congress 2020

    Noninvasive brain stimulation to treat hypokinetic dysarthria in PD: A sham stimulation-controlled trial

    I. Rektorova, L. Brabenec, P. Klobusiakova, M. Kostalova (Brno, Czech Republic)

    Objective: To treat hypokinetic dysarthria (HD) in PD patients using multiple sessions repetitive transcranial magnetic stimulation (rTMS) Background: Based on results from our rTMS exploratory…
  • MDS Virtual Congress 2020

    Levodopa induced changes of tongue body movements during speech production

    T. Thies, D. Mücke, R. Dano, M.. Barbe (Cologne, Germany)

    Objective: This study investigates the influence of levodopa (L-dopa) on tongue body movements during speaking. Background: Parkinson’s disease (PD) is a neurodegenerative disorder affecting non-motor…
  • MDS Virtual Congress 2020

    Speech biometrics can predict cerebellar dysfunction in multiple sclerosis

    A. Vogel, G. Noffs, F. Boonstra, T. Perera, S. Kolbe, J. Stankovich, H. Butzkueven, A. Evans, A. der Walt (Melbourne, Australia)

    Objective: To objectively describe cerebellar mediated speech function using a multiparameter index that reflects pathology and quality of life in MS. Background: Cerebellar function plays…
  • MDS Virtual Congress 2020

    Cross-linguistic exploration of speech treatment for Parkinson’s disease: is a universal speech treatment approach plausible?

    C. Fox (Tucson, AZ, USA)

    Objective: Examine speech treatment outcomes in people with Parkinson’s disease (PD) across different languages to explore the plausibility of a universal speech treatment approach. Background:…
  • MDS Virtual Congress 2020

    A Virtual Speech Therapist for Parkinson’s Disease

    A. Halpern, L. Ramig, R. Cole (Denver, CO, USA)

    Objective: This study was designed as a pilot investigation to explore the use of virtual therapy in the delivery of LSVT LOUD ® (Lee Silverman…
  • MDS Virtual Congress 2020

    LSVT LOUD Applied to Adults with Cerebral Palsy: Two Single-Subject Studies

    G. Moya-Gale, J. Galgano, C. Ferrone, Y. Chang, G. Tsang, L. Ramig (Brooklyn, NY, USA)

    Objective: To examine treatment-related acoustic and perceptual changes after LSVT LOUD ® in two adult speakers with dysarthria secondary to cerebral palsy (CP). Background: Cerebral…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley